Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study
Clinical Trial
[키워드] adipose
administration
adverse event
adverse events
assigned
chest imaging
Clinical characteristics
clinical study
COVID-19
COVID-19 patient
COVID-19 patients
D-dimer
daily dose
demographic data
dose
Efficacy
Efficiency
enrolled
event
Evidence
Exosome
Exosomes
Extracellular vesicles
feasible
females
Hospital admission
IL-6
incidence
inhalation
interquartile range
IQR
laboratory result
Lymphocyte count
male
median
median age
median time
Mesenchymal stromal cell.
MSC
nebulized
onset of symptom
Patient
patients
patients with COVID-19
pilot study
Pneumonia
Primary outcome
pulmonary lesion
receive
safety profile
Serious Adverse Events
serum
Seven
severe COVID-19
single-arm
slight increase
stromal cell
supported
tested
tissue
Toxicity
Treatment
Trial
Vesicle
vesicles
Wuhan, China
[DOI] 10.1186/s13287-022-02900-5 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1186/s13287-022-02900-5 PMC 바로가기 [Article Type] Clinical Trial